{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T11:29:34Z","timestamp":1784806174258,"version":"3.55.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"publisher","award":["Z171100001117119"],"award-info":[{"award-number":["Z171100001117119"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022M723905"],"award-info":[{"award-number":["2022M723905"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFA0902300"],"award-info":[{"award-number":["2018YFA0902300"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.bbrc.2025.151458","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T01:25:49Z","timestamp":1738805149000},"page":"151458","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Development and application of a high-titer VSV-based HCoV-NL63 pseudovirus system via C-terminal 14 amino acid truncation of spike"],"prefix":"10.1016","volume":"751","author":[{"given":"Li-ting","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-rong","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-guo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5895-936X","authenticated-orcid":false,"given":"Xue-jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2025.151458_bib1","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1093\/infdis\/jiy098","article-title":"Human coronavirus NL63 molecular epidemiology and evolutionary patterns in rural coastal Kenya","volume":"217","author":"Kiyuka","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bbrc.2025.151458_bib2","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02503-16","article-title":"Structural characterization of human coronavirus NL63 N protein","volume":"91","author":"Szelazek","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrc.2025.151458_bib3","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.3201\/eid1108.050110","article-title":"Human coronavirus NL63, France","volume":"11","author":"Vabret","year":"2005","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.bbrc.2025.151458_bib4","article-title":"Mouse models susceptible to HCoV-229E and HCoV-NL63 and cross protection from challenge with SARS-CoV-2","volume":"120","author":"Liu","year":"2023","journal-title":"P Natl Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2025.151458_bib5","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41586-023-06761-7","article-title":"TMPRSS2 is a functional receptor for human coronavirus HKU1","volume":"624","author":"Saunders","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2025.151458_bib6","first-page":"763","article-title":"Epidemiology of human coronavirus NL63 infection among hospitalized patients with pneumonia in Taiwan","volume":"50","author":"Huang","year":"2017","journal-title":"J. Microbiol. Immunol."},{"key":"10.1016\/j.bbrc.2025.151458_bib7","doi-asserted-by":"crossref","first-page":"292","DOI":"10.18683\/germs.2022.1331","article-title":"Severe coronavirus HCoV-NL63 pneumonia in a patient receiving blinatumomab with secondary antibody deficiency in COVID-19 times","volume":"12","author":"Paredes-Amaya","year":"2022","journal-title":"Germs"},{"key":"10.1016\/j.bbrc.2025.151458_bib8","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/s43018-020-00107-2","article-title":"Pseudovirus for immunotherapy","volume":"1","author":"Kepp","year":"2020","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.bbrc.2025.151458_bib9","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1080\/22221751.2020.1743767","article-title":"Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2","volume":"9","author":"Nie","year":"2020","journal-title":"Emerg Microbes. Infec."},{"key":"10.1016\/j.bbrc.2025.151458_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2022.126993","article-title":"Application of pseudovirus system in the development of vaccine, antiviral-drugs, and neutralizing antibodies","volume":"258","author":"Xiang","year":"2022","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.bbrc.2025.151458_bib11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bj.2020.06.003","article-title":"Assessing the application of a pseudovirus system for emerging SARS-CoV-2 and re-emerging avian influenza virus H5 subtypes in vaccine development","volume":"43","author":"Huang","year":"2020","journal-title":"Biomed. J."},{"key":"10.1016\/j.bbrc.2025.151458_bib12","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.vaccine.2013.09.007","article-title":"Assessment of HPV 16 and HPV 18 antibody responses by pseudovirus neutralization, Merck cLIA and Merck total IgG LIA immunoassays in a reduced dosage quadrivalent HPV vaccine trial","volume":"32","author":"Krajden","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.bbrc.2025.151458_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14081597","article-title":"A pseudovirus nanoparticle-based trivalent rotavirus vaccine candidate elicits high and cross P type immune response","volume":"14","author":"Xia","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bbrc.2025.151458_bib14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.phrp.2011.04.006","article-title":"Infectivity of homologous recombinant HIV-1 pseudo-virus with reverse transcriptase inhibitor-related mutations from highly active antiretroviral therapy experienced patients","volume":"2","author":"Kwon","year":"2011","journal-title":"Osong Public Health Res Perspect"},{"key":"10.1016\/j.bbrc.2025.151458_bib15","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.18632\/oncotarget.27799","article-title":"MEK inhibitors reduce cellular expression of ACE2, pERK, pRb while stimulating NK-mediated cytotoxicity and attenuating inflammatory cytokines relevant to SARS-CoV-2 infection","volume":"11","author":"Zhou","year":"2020","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2025.151458_bib16","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1128\/JVI.00094-12","article-title":"Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry","volume":"86","author":"Kawase","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrc.2025.151458_bib17","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.virusres.2011.06.029","article-title":"Characterization of the spike protein of human coronavirus NL63 in receptor binding and pseudotype virus entry","volume":"160","author":"Lin","year":"2011","journal-title":"Virus Res."},{"key":"10.1016\/j.bbrc.2025.151458_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2021.114221","article-title":"An optimized and robust SARS-CoV-2 pseudovirus system for viral entry research","volume":"295","author":"Yang","year":"2021","journal-title":"J. Virol Methods"},{"key":"10.1016\/j.bbrc.2025.151458_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01840-21","article-title":"The large nonstructural protein (NS1) of human bocavirus 1 directly interacts with Ku70, which plays an important role in virus replication in human airway epithelia","volume":"96","author":"Shao","year":"2022","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrc.2025.151458_bib20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1247\/csf.21047","article-title":"A method for the generation of pseudovirus particles bearing SARS coronavirus spike protein in high yields","volume":"47","author":"Fujioka","year":"2022","journal-title":"Cell Struct. Funct."},{"key":"10.1016\/j.bbrc.2025.151458_bib21","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1099\/vir.0.80955-0","article-title":"Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein","volume":"86","author":"Fukushi","year":"2005","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.bbrc.2025.151458_bib22","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/1743-422X-10-266","article-title":"A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV","volume":"10","author":"Zhao","year":"2013","journal-title":"Virol. J."},{"key":"10.1016\/j.bbrc.2025.151458_bib23","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/22221751.2020.1717999","article-title":"Discovery of a subgenotype of human coronavirus NL63 associated with severe lower respiratory tract infection in China, 2018","volume":"9","author":"Wang","year":"2020","journal-title":"Emerg Microbes. Infec."},{"key":"10.1016\/j.bbrc.2025.151458_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01639-22","article-title":"Human air-liquid-interface organotypic airway cultures express significantly more ACE2 receptor protein and are more susceptible to HCoV-NL63 infection than monolayer cultures of primary respiratory epithelial cells","volume":"10","author":"Castillo","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.bbrc.2025.151458_bib25","first-page":"3","article-title":"The origins of severe acute respiratory syndrome-coronavirus-2","volume":"44","author":"Dwyer","year":"2023","journal-title":"Semin Resp. Crit Care"},{"key":"10.1016\/j.bbrc.2025.151458_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/v15030736","article-title":"SARS-CoV-2 is more efficient than HCoV-NL63 in infecting a small subpopulation of ACE2+ human respiratory epithelial cells","volume":"15","author":"Castillo","year":"2023","journal-title":"Viruses-Basel"},{"key":"10.1016\/j.bbrc.2025.151458_bib27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41392-020-0190-2","article-title":"Overview of lethal human coronaviruses","volume":"5","author":"Chen","year":"2020","journal-title":"Signal Transduct Tar"},{"key":"10.1016\/j.bbrc.2025.151458_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijc.25242","article-title":"Check your cultures! A list of cross-contaminated or misidentified cell lines","volume":"127","author":"Capes-Davis","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbrc.2025.151458_bib29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41392-021-00531-5","article-title":"Identification of bis-benzylisoquinoline alkaloids as SARS-CoV-2 entry inhibitors from a library of natural products","volume":"6","author":"He","year":"2021","journal-title":"SIGNAL TRANSDUCT TAR"},{"key":"10.1016\/j.bbrc.2025.151458_bib30","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/s41467-024-45690-5","article-title":"Cepharanthine analogs mining and genomes of Stephania accelerate anti-coronavirus drug discovery","volume":"15","author":"Leng","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2025.151458_bib31","doi-asserted-by":"crossref","first-page":"5825","DOI":"10.1002\/jmv.27117","article-title":"Inhibitory effect on SARS-CoV-2 infection of neferine by blocking Ca(2+) -dependent membrane fusion","volume":"93","author":"Yang","year":"2021","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.bbrc.2025.151458_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2282","article-title":"An overview on the seven pathogenic human coronaviruses","volume":"32","author":"Kesheh","year":"2022","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.bbrc.2025.151458_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/v14071551","article-title":"Origins and evolution of seasonal human coronaviruses","volume":"14","author":"Otieno","year":"2022","journal-title":"Viruses-Basel"},{"key":"10.1016\/j.bbrc.2025.151458_bib34","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1093\/cid\/ciaa1386","article-title":"Systematically mapping clinical features of infections with classical endemic human coronaviruses","volume":"73","author":"Li","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bbrc.2025.151458_bib35","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1007\/s00705-015-2506-z","article-title":"Inability of rat DPP4 to allow MERS-CoV infection revealed by using a VSV pseudotype bearing truncated MERS-CoV spike protein","volume":"160","author":"Fukuma","year":"2015","journal-title":"Arch. Virol."},{"key":"10.1016\/j.bbrc.2025.151458_bib36","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/jmv.26362","article-title":"More than just a common cold: endemic coronaviruses OC43, HKU1, NL63, and 229E associated with severe acute respiratory infection and fatality cases among healthy adults","volume":"93","author":"Veiga","year":"2021","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.bbrc.2025.151458_bib37","article-title":"Concerns on Bebtelovimab (LY-CoV1404) used to neutralize Omicron subvariants","volume":"95","author":"Wang","year":"2023","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.bbrc.2025.151458_bib38","article-title":"Structure of main protease from human coronavirus NL63: insights for wide spectrum anti-coronavirus drug design","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep-UK"},{"key":"10.1016\/j.bbrc.2025.151458_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2023.199078","article-title":"Molecular mechanisms of human coronavirus NL63 infection and replication","volume":"327","author":"Castillo","year":"2023","journal-title":"Virus Res."},{"key":"10.1016\/j.bbrc.2025.151458_bib40","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01062-20","article-title":"Optimized pseudotyping conditions for the SARS-COV-2 spike glycoprotein","volume":"94","author":"Johnson","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrc.2025.151458_bib41","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13578-021-00626-0","article-title":"Deletion of ER-retention motif on SARS-CoV-2 spike protein reduces cell hybrid during cell-cell fusion","volume":"11","author":"Wang","year":"2021","journal-title":"Cell Biosci."},{"key":"10.1016\/j.bbrc.2025.151458_bib42","doi-asserted-by":"crossref","first-page":"5333","DOI":"10.1038\/s41467-021-25589-1","article-title":"Sequences in the cytoplasmic tail of SARS-CoV-2 Spike facilitate expression at the cell surface and syncytia formation","volume":"12","author":"Cattin-Ortola","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2025.151458_bib43","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.3390\/v7041700","article-title":"Incorporation of spike and membrane glycoproteins into coronavirus virions","volume":"7","author":"Ujike","year":"2015","journal-title":"Viruses-Basel"},{"key":"10.1016\/j.bbrc.2025.151458_bib44","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1016\/j.apsb.2023.04.007","article-title":"SARS-CoV-2 spike host cell surface exposure promoted by a COPI sorting inhibitor","volume":"13","author":"Li","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bbrc.2025.151458_bib45","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01758-18","article-title":"Deletion of both the tyrosine-based endocytosis signal and the endoplasmic reticulum retrieval signal in the cytoplasmic tail of spike protein attenuates porcine epidemic diarrhea virus in pigs","volume":"93","author":"Hou","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrc.2025.151458_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134310","article-title":"Targeting microglia with lentivirus and AAV: recent advances and remaining challenges","volume":"707","author":"Maes","year":"2019","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbrc.2025.151458_bib47","doi-asserted-by":"crossref","first-page":"32840","DOI":"10.1021\/acsomega.2c03517","article-title":"Emerging biomedical applications of the vesicular stomatitis virus glycoprotein","volume":"7","author":"Rehman","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.bbrc.2025.151458_bib48","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.chom.2020.06.021","article-title":"Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2","volume":"28","author":"Case","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.bbrc.2025.151458_bib49","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1080\/22221751.2022.2071175","article-title":"Virus-host interaction networks as new antiviral drug targets for IAV and SARS-CoV-2","volume":"11","author":"Chen","year":"2022","journal-title":"Emerg Microbes. Infec."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2500172X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2500172X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T14:52:30Z","timestamp":1762095150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X2500172X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":49,"alternative-id":["S0006291X2500172X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.151458","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and application of a high-titer VSV-based HCoV-NL63 pseudovirus system via C-terminal 14 amino acid truncation of spike","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.151458","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"151458"}}